Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority claimed from PCT/IB2014/002868external-prioritypatent/WO2015097536A2/en
Publication of JOP20200184A1publicationCriticalpatent/JOP20200184A1/en
ABSTRACT OF THE DISCLOSURE The present invention relates to novel antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of making and using same. Methods of use include methods of treatment of cancer, including leukemias, lymphomas, solid tumors and melanomas.
JOP/2020/0184A2013-12-242013-12-24Anti-VISTA Antibodies And Fragments
JOP20200184A1
(en)